Gyno-Pevaryl

Gyno-Pevaryl is a vaginal antifungal product containing the active ingredient econazole nitrate. It is marketed in the European Union and is formulated for intravaginal use to treat fungal infections. As an imidazole‑type antifungal, econazole nitrate works by inhibiting ergosterol synthesis in fungal cell membranes. The product does not specify a fixed strength in publicly available sources, and it is supplied without a brand‑specific manufacturer name.

Gyno-Pevaryl is indicated for the treatment of vaginal yeast infections caused by susceptible Candida species.

- Management of acute vulvovaginal candidiasis. - Adjunct therapy for recurrent Candida infections when prescribed by a clinician. - Treatment of symptomatic vaginal yeast overgrowth confirmed by laboratory testing. - Relief of itching, burning, and discharge associated with Candida vaginitis. - Option for patients who prefer a vaginal route over oral antifungal agents. - Use in patients requiring a topical antifungal with a low systemic absorption profile.

Possible adverse reactions to Gyno-Pevaryl have been reported, most of which are mild and reversible.

Common: - Local irritation or burning at the application site. - Vaginal itching or mild discomfort. - Unpleasant odor or discharge unrelated to infection. - Vaginal dryness. - Mild abdominal cramps. - Headache (rarely reported).

Serious: - Severe allergic reaction such as rash, swelling, or difficulty breathing. - Persistent or worsening vaginal symptoms despite treatment. - Development of secondary bacterial infection. - Signs of systemic toxicity such as nausea or dizziness.

Before using Gyno-Pevaryl, certain precautions should be considered to ensure safe and effective therapy.

- Confirm diagnosis of Candida infection before initiating treatment. - Avoid use if known hypersensitivity to econazole nitrate or other imidazoles. - Do not use during active vaginal bleeding or menstruation unless directed by a healthcare professional. - Discuss pregnancy, lactation, or planned pregnancy with a clinician, as safety data are limited. - Inform the prescriber of any existing vaginal conditions, such as ulcerations or severe irritation. - Use only the prescribed duration; prolonged use may increase risk of resistance.

Econazole nitrate may interact with other medications or substances applied vaginally, and systemic interactions are possible when absorption occurs.

Avoid: - Concurrent use of other intravaginal antifungal agents without medical advice. - Simultaneous application of vaginal spermicides or lubricants containing oil‑based formulations that could affect drug absorption.

Use with caution: - Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase risk of hepatic enzyme inhibition. - Hormonal contraceptives, because altered vaginal flora could affect efficacy. - Topical corticosteroids applied to the vagina, which may mask local irritation.